Economics to boost antibiotics development
Considering the importance of antibiotics for our healthcare, the issue of a dwindling development pipeline must be addressed. This article […]
Will bonding curves be researchers’ best friends?
Continuous token bonding curves, formerly referred to as curation markets, describe a blockchain framework that is different from the concept […]
Paying for patient expertise
Scientists in academic or other institutions use the unique insights patients provide to inform their research. Pharmaceutical companies oftentimes look […]
Justifying health insurance expenditure
It can be difficult for public health insurers to decide which medical interventions to cover. After all, it is the […]
Gender transition is in transition
Transgender health management has seen important advances in the recent past. Some notable remaining issues revolve around the standard of […]
Organ donation part 3/4 – The futures that never happened
Futures contracts for donations after death appear to ease major ethical concerns in the debate about payment for human organs. […]
Organ donation part 2/4 – Which incentives are there?
It has been argued for decades that meaningful incentives are needed for substantially more individuals to donate organs. Existing and […]
The future(s) of healthcare?
Planning and financing healthcare is a challenging task for individuals, private insurance providers and governments. Public and private insurances must […]